Point of Care (POC) Diagnostic Market by Types, Applications, Countries, Companies and Forecasts to 2025 covered in a Latest Research
Point of Care (POC) Diagnostic Market from Qurate Business Intelligence provides detailed information, in depth analysis and forecast which is developed by team of experts and professionals.
(EMAILWIRE.COM, September 15, 2018 ) The Global Point of Care Diagnostic market was valued at USD 15.4 Billion in 2015, and is projected to reach USD 28.7 billion by 2025, growing at a CAGR of 5% over the forecast period.
Key players: Overview of market leaders in POC Diagnotics market by top manufacturers/players, with revenue (Billion USD) and market share for each manufacturer/player. The top players including include Abbott Laboratories, bioMιrieux SA, Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd.), Abaxis, Siemens, EKF Diagnostics, Danaher, Instrumentation Laboratory, Healthineers, Nova Biomedical, Quidel Corporation, Trinity Biotech, Chembio Diagnostics, Sekisui Diagnostics LLC, Trividia Health, Inc., OraSure Technologies Inc, Becton Dickinson & Company (BD), and Johnson & Johnson Services, Inc.
Get Sample Copy of This Report@ www.qurateresearch.com/report/sample/HnM/QBI-XPR-HnM-55955
Emerging technological advancements in biosensors, smartphones, wearable devices and lab-on-a-chip are transforming the point of care diagnostic market. The POC diagnostics industry has been expected to be a part of paradigm shift from curative medicine to predictive, preemptive and personalized medicine. POC diagnostic tests are either antibody-based or microbial particle-based, assisting in decreasing the interval between diagnosis and treatment of a disease.
High prevalence of infectious diseases in emerging nations, increasing preferences for home healthcare option, and rising incidences of target diseases across the globe are few factors gaining the traction of POC diagnostic products globally. It has been expected that the number of cellphone users have passed 7.4 billion in emerging countries and the population in the countries is marred by various communicable/non-communicable diseases.
Furthermore, increasing chronic diseases, rapid upsurge in the aging population, and rising consumer awareness are also positively influencing the POC diagnostic market. Henceforth, Point-of-Care Diagnostics has been predicted to be a revolutionary aid in treatment procedures and projecting emerging countries to be a highly profitable market for POC Diagnostics.
Buy This Report@ www.qurateresearch.com/report/buy/HnM/QBI-XPR-HnM-55955/ (Priced at USD 4199)
The report includes -
Segmentation: Based on product segment, the POC diagnostic market has been bifurcated and the report displays the market share, growth and revenue of each type:
Glucose Monitoring.
Cardiometabolic Testing
Infectious Disease Testing
Coagulation Testing
Pregnancy & Fertility Testing
Tumor/Cancer Marker Testing
Urinalysis Testing
Cholesterol Testing
Cholesterol Testing
Hematology Testing
Drugs-of-Abuse Testing
Fecal Occult Testing
Other
On the basis on the end-users, this report focuses on the status and outlook for major applications, market share and growth rate for each application, including
Professional Diagnostic Centers
Hospitals
Home Care
Clinics
Others
Enquiry about Report@ www.qurateresearch.com/report/enquiry/HnM/QBI-XPR-HnM-55955
Geographic Segmentation: This report split global market into North America, Europe, Asia Pacific, the Middle East and Africa and Latin America, with revenue (Billion USD), market share and growth rate of POC Diagnostics for these regions, from 2015 to 2025 (forecast)
North America: U.S., Rest of North America
Europe: Germany, France, UK, rest of Europe
Asia Pacific: China, Japan, India and Rest of Asia Pacific
Middle East & Africa: GCC, North Africa, South Africa and Rest of MEA
Latin America: Brazil and Rest of Latin America
Key players: Overview of market leaders in POC Diagnotics market by top manufacturers/players, with revenue (Billion USD) and market share for each manufacturer/player. The top players including include Abbott Laboratories, bioMιrieux SA, Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd.), Abaxis, Siemens, EKF Diagnostics, Danaher, Instrumentation Laboratory, Healthineers, Nova Biomedical, Quidel Corporation, Trinity Biotech, Chembio Diagnostics, Sekisui Diagnostics LLC, Trividia Health, Inc., OraSure Technologies Inc, Becton Dickinson & Company (BD), and Johnson & Johnson Services, Inc.
Get Sample Copy of This Report@ www.qurateresearch.com/report/sample/HnM/QBI-XPR-HnM-55955
Emerging technological advancements in biosensors, smartphones, wearable devices and lab-on-a-chip are transforming the point of care diagnostic market. The POC diagnostics industry has been expected to be a part of paradigm shift from curative medicine to predictive, preemptive and personalized medicine. POC diagnostic tests are either antibody-based or microbial particle-based, assisting in decreasing the interval between diagnosis and treatment of a disease.
High prevalence of infectious diseases in emerging nations, increasing preferences for home healthcare option, and rising incidences of target diseases across the globe are few factors gaining the traction of POC diagnostic products globally. It has been expected that the number of cellphone users have passed 7.4 billion in emerging countries and the population in the countries is marred by various communicable/non-communicable diseases.
Furthermore, increasing chronic diseases, rapid upsurge in the aging population, and rising consumer awareness are also positively influencing the POC diagnostic market. Henceforth, Point-of-Care Diagnostics has been predicted to be a revolutionary aid in treatment procedures and projecting emerging countries to be a highly profitable market for POC Diagnostics.
Buy This Report@ www.qurateresearch.com/report/buy/HnM/QBI-XPR-HnM-55955/ (Priced at USD 4199)
The report includes -
Segmentation: Based on product segment, the POC diagnostic market has been bifurcated and the report displays the market share, growth and revenue of each type:
Glucose Monitoring.
Cardiometabolic Testing
Infectious Disease Testing
Coagulation Testing
Pregnancy & Fertility Testing
Tumor/Cancer Marker Testing
Urinalysis Testing
Cholesterol Testing
Cholesterol Testing
Hematology Testing
Drugs-of-Abuse Testing
Fecal Occult Testing
Other
On the basis on the end-users, this report focuses on the status and outlook for major applications, market share and growth rate for each application, including
Professional Diagnostic Centers
Hospitals
Home Care
Clinics
Others
Enquiry about Report@ www.qurateresearch.com/report/enquiry/HnM/QBI-XPR-HnM-55955
Geographic Segmentation: This report split global market into North America, Europe, Asia Pacific, the Middle East and Africa and Latin America, with revenue (Billion USD), market share and growth rate of POC Diagnostics for these regions, from 2015 to 2025 (forecast)
North America: U.S., Rest of North America
Europe: Germany, France, UK, rest of Europe
Asia Pacific: China, Japan, India and Rest of Asia Pacific
Middle East & Africa: GCC, North Africa, South Africa and Rest of MEA
Latin America: Brazil and Rest of Latin America
Contact Information:
Qurate Business Intelligence
Nehal Chinoy
Tel: +919881074592
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Qurate Business Intelligence
Nehal Chinoy
Tel: +919881074592
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results